Status | Study |
Not yet recruiting |
Study Name: A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type. Condition: Alzheimer's Disease Date: 2016-12-08 Interventions: Drug: Rivastigmine |
Terminated |
Study Name: Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus. Condition: Keratoconus Date: 2016-05-03 Interventions: Drug: Riboflavin drops Riboflavin drops were used every 2 minutes for 30 minutes on the cornea then expo |
Recruiting |
Study Name: Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia Condition: Arnold-Chiari Malformation, Type 1 Chiari Malformation Type I Date: 2016-01-13 Interventions: Procedure: Posterior fossa decompression |
Recruiting |
Study Name: Efficacy of Acetaminophen in Posterior Fossa Surgery Condition: Arnold-Chiari Malformation Posterior Fossa Tumors Date: 2015-08-21 Interventions: Drug: IV acetaminophen IV acet |
Completed |
Study Name: Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest Condition: Actinic Keratosis Date: 2015-02-02 Interventions: Drug: Ingenol Mebutate Other: Vehicle |
Completed |
Study Name: Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis Condition: Actinic Keratosis Date: 2014-04-18 Interventions: Drug: LEO 43204 Drug: Placebo |
Completed |
Study Name: Corneal Cross-Linking Comparing Variables Condition: Unstable Corneas Date: 2014-03-20 Interventions: Drug: Epithelium-On Riboflavin |
Recruiting |
Study Name: Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2 Condition: Keratoconus Corneal Ectasia Date: 2013-12-09 Interventions: Drug: Riboflavin 0.1% ophthalmic solution |
Completed |
Study Name: Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis Condition: Actinic Keratosis Date: 2013-11-21 Interventions: Drug: ingenol mebutate Other: Placebo |
Recruiting |
Study Name: NOVOCART®3D for Treatment of Articular Cartilage of the Knee Condition: Articular Cartilage of the Femoral Condyle Between 2-6cm2 Date: 2013-09-17 Interventions: Procedure: microfracture Surgi |